Compares treatment options for Postoperative Pain
Official title EXORA vs ESP Blocks in Laparoscopic Cholecystectomy
ClinicalTrials.gov ID: NCT07187310
What this study is testing
- What it's testing
- Laparoscopic cholecystectomy is still considered the gold standard for the surgical management of gallbladder disease due to its minimally invasive nature, shorter recovery time, and reduced postoperative complications. Despite these advantages, patients frequently experience moderate to severe postoperative pain, particularly in the early postoperative period, which can impede recovery, delay mobilization, and increase opioid consumption.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Elective laparoscopic cholecystectomy
- ASA physical status I-III
You likely can't join if
- Known allergy to local anesthetics
- Chronic pain or regular opioid use
- Coagulopathy or anticoagulant therapy
- Local infection at the block site
- BMI more than 35 kg/m2
- Neurological or psychiatric disorders
See the full eligibility criteria
- Elective laparoscopic cholecystectomy
- ASA physical status I-III
- Known allergy to local anesthetics
- Chronic pain or regular opioid use
- Coagulopathy or anticoagulant therapy
- Local infection at the block site
- BMI more than 35 kg/m2
- Neurological or psychiatric disorders
- Refusal to participate
The study team makes the final eligibility decision.
Where it's taking place
- El Fayoum Qesm, Faiyum Governorate, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include El Fayoum Qesm, Faiyum Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.